摘要
目的分析厄贝沙坦联合氨氯地平治疗高血压合并冠心病患者的临床疗效。方法选择我院2015年3月—2016年5月收治的102例高血压合并冠心病患者,对常规组单纯采取厄贝沙坦治疗,实验组在此基础上加用氨氯地平治疗。结果实验组与常规组的治疗总有效率分别为96.08%与82.35%,P<0.05;治疗前两组患者血压水平无明显差异,治疗后实验组患者舒张压与收缩压改善程度明显优于常规组,P<0.05。结论对高血压合并冠心病患者采取厄贝沙坦联合氨氯地平进行治疗可达到良好的临床疗效。
Objective To analyze the clinical efficacy of irbesartan combined with amlodipine in the treatment of hypertensive patients with coronary heart disease. Methods 102 patients with hypertension and coronary heart disease were treated in our hospital from March 2015 to May 2016. The patients in the routine group were treated with irbesartan only, and the experimental group was treated with amlodipine on this basis. Results The total effective rate of the experimental group and the routine group was 96.08% and 82.35%, P〈0.05, respectively. There was no significant difference in blood pressure between the two groups before treatment. The improvement of diastolic blood pressure and systolic blood pressure in the experimental group was significantly better than that in the routine group, P〈0.05. Conelusion The treatment of irbesartan combined with amlodipine in patients with hypertension and coronary heart disease can achieve good clinical efficacy.
出处
《中国继续医学教育》
2017年第12期186-188,共3页
China Continuing Medical Education
关键词
高血压
冠心病
厄贝沙坦
氨氯地平
hypertension
coronary heart disease
irbesartan
amlodipine
